Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$70.30

1.73 (2.52%)

08:20
10/06/16
10/06
08:20
10/06/16
08:20

Alnylam price target lowered to $100 from $150 at Cowen

Cowen analyst Ritu Baral noted Alnylam announced the discontinuation of revusiran for the treatment of hereditary ATTR amyloidosis with cardiomyopathy due to risk/benefit and safety signals. The analyst does not believe it signals any risk to the platform, as other programs have shown solid safety. Baral said revusiran was a minor driver so she maintained her Outperform rating and lowered her price target to $100 from $150 on Alnylam shares.

  • 14

    Oct

  • 06

    Nov

ALNY Alnylam
$70.30

1.73 (2.52%)

10/06/16
JEFF
10/06/16
NO CHANGE
Target $43
JEFF
Buy
Alnylam setback has no read-through to Medicines Co., says Jefferies
Jefferies analyst Biren Amin believes Alnylam Pharmaceuticals' (ALNY) decision to stop revusiran due to lack of a treatment benefit has no read-through to The Medicines Co.'s (MDCO) PCSK9 program. Amin keeps a Buy rating on Medicines Co. with a $43 price target.
10/06/16
JEFF
10/06/16
NO CHANGE
Target $58
JEFF
Buy
Alnylam price target lowered to $58 from $86 at Jefferies
Jefferies analyst Gena Wang lowered her price target for Alnylam Pharmaceuticals to $58 from $86 following the termination of revusiran Phase 3 due to mortality imbalance. The analyst believes the setback, while "major," is likely to be program specific and not impact the company's other trials. She keeps a Buy rating on Alnylam.
10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Alnylam news not a negative read through on other RNAi drugs, says RBC Capital
After Alnylam (ALNY) announced that it was discontinuing one of its Phase III RNAi drugs due to poor clinical outcomes, RBC Capital analyst Michael Yee does not thinks that the news indicates problems with all RNAi drugs. Rather, he thinks that RNAi was not the proper treatment for the disease that Alnylam was targeting. Other companies with RNAi treatments include The Medicines Company (MDCO0, Ionis Pharmaceuticals (IONS), Arrowhead (ARWR), and Arbutus Biopharma (ABUS).
10/06/16
WELS
10/06/16
NO CHANGE
WELS
Ionis has no read through from negative Alnylam data, says Wells Fargo
After Ionis (IONS) competitor Alnylam Pharmaceuticals (ALNY) announced that it was terminating the development of its revusiran RNAi drug due to poor outcomes in clinical trials, Wells Fargo thinks that the news is "a significant positive" for Ionis because it eliminates a competitor. The firm says that Ionis' drug is significantly different than Alnylam's product, and it believes that Ionis' treatment appears to be superior. The firm keeps an Outperform rating on Ionis.

TODAY'S FREE FLY STORIES

AAL

American Airlines

$45.31

-0.69 (-1.50%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Options
American Airlines call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

HQY

HealthEquity

$45.77

0.65 (1.44%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Conference/Events
HealthEquity participates in a conference call with Chardan »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

NHI

National Health Investors

$79.82

-0.175 (-0.22%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Conference/Events
National Health Investors to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

OPXA

Opexa Therapeutics

$1.09

0.07 (6.86%)

11:25
09/19/17
09/19
11:25
09/19/17
11:25
Conference/Events
Opexa Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

JKS

JinkoSolar

$27.78

0.14 (0.51%)

, JASO

JA Solar

$8.14

0.25 (3.17%)

11:21
09/19/17
09/19
11:21
09/19/17
11:21
Periodicals
EU eases trade restrictions on Chinese solar panels, People's Daily reports »

China has welcomed the…

JKS

JinkoSolar

$27.78

0.14 (0.51%)

JASO

JA Solar

$8.14

0.25 (3.17%)

CSIQ

Canadian Solar

$16.80

-0.47 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

, EFII

Electronics for Imaging

$41.56

-0.03 (-0.07%)

11:21
09/19/17
09/19
11:21
09/19/17
11:21
Hot Stocks
NuVasive slides as GlassHouse Research sees 'profusion of accounting red flags' »

GlassHouse Research noted…

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

EFII

Electronics for Imaging

$41.56

-0.03 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

$NSD

NASDAQ Market Internals

11:17
09/19/17
09/19
11:17
09/19/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIR

AAR Corp.

$36.87

0.32 (0.88%)

11:16
09/19/17
09/19
11:16
09/19/17
11:16
Hot Stocks
AAR Corp. to acquire two MRO facilities from Premier Aviation »

AAR announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

$NYE

NYSE Market Internals

11:16
09/19/17
09/19
11:16
09/19/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
09/19/17
09/19
11:15
09/19/17
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

BBY

Best Buy

$52.43

-4.92 (-8.58%)

11:13
09/19/17
09/19
11:13
09/19/17
11:13
Technical Analysis
Technical View: Best Buy falls to session lows following outlook »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SIEGY

Siemens

$69.98

0.26 (0.37%)

11:11
09/19/17
09/19
11:11
09/19/17
11:11
Hot Stocks
Siemens, PAS announce partnership to provide monitoring for control systems »

Siemens and PAS Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$58.51

0.395 (0.68%)

11:10
09/19/17
09/19
11:10
09/19/17
11:10
Options
Repeat of bullish option activity in UAL »

Repeat of bullish option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

VIAB

Viacom

$27.32

-0.35 (-1.26%)

, DISCA

Discovery

$21.32

-0.62 (-2.83%)

11:08
09/19/17
09/19
11:08
09/19/17
11:08
Hot Stocks
Cowen sees more trouble ahead for traditional TV names »

Research firm Cowen cut…

VIAB

Viacom

$27.32

-0.35 (-1.26%)

DISCA

Discovery

$21.32

-0.62 (-2.83%)

FOXA

21st Century Fox

$26.50

-0.55 (-2.03%)

DIS

Disney

$98.43

0.325 (0.33%)

CBS

CBS

$57.71

-0.01 (-0.02%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

FB

Facebook

$170.01

-1.63 (-0.95%)

NFLX

Netflix

$184.62

2.27 (1.24%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 16

    Oct

  • 29

    Nov

XON

Intrexon

$19.19

-0.28 (-1.44%)

11:07
09/19/17
09/19
11:07
09/19/17
11:07
Hot Stocks
Intrexon's Oxitec plans to build centralized mosquito egg production unit »

Oxitec, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRCM

Care.com

$14.45

-0.14 (-0.96%)

11:04
09/19/17
09/19
11:04
09/19/17
11:04
Hot Stocks
Care.com names George Bell to board as lead independent director »

Care.com yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTB

M&T Bank

$152.67

1 (0.66%)

11:03
09/19/17
09/19
11:03
09/19/17
11:03
Hot Stocks
M&T Bank enters community-focused strategic partnership with NY Jets »

The New York Jets and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$88.33

-6.25 (-6.61%)

11:02
09/19/17
09/19
11:02
09/19/17
11:02
Hot Stocks
Coordinated Care awarded Commendable Accreditation status from NCQA »

Coordinated Care, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

USB

U.S. Bancorp

$52.64

0.255 (0.49%)

11:01
09/19/17
09/19
11:01
09/19/17
11:01
Hot Stocks
U.S. Bancorp boosts quarterly dividend by 7% to 30c »

U.S. Bancorp said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 17

    Jan

NUVA

NuVasive

$57.80

-0.68 (-1.16%)

11:01
09/19/17
09/19
11:01
09/19/17
11:01
Periodicals
NuVasive mentioned cautiously in short report from GlassHouse Research 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGC

Regal Entertainment

$16.08

-0.365 (-2.22%)

11:00
09/19/17
09/19
11:00
09/19/17
11:00
Conference/Events
Regal Entertainment management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Sep

  • 02

    Oct

T

AT&T

$37.94

0.515 (1.38%)

11:00
09/19/17
09/19
11:00
09/19/17
11:00
Options
AT&T option volume double normal as implied volatility term structure inverts »

AT&T option volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

KR

Kroger

$21.32

-0.12 (-0.56%)

10:59
09/19/17
09/19
10:59
09/19/17
10:59
Hot Stocks
Kroger outlook revised to Negative from Stable by Fitch »

Fitch affirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 30

    Nov

TSLA

Tesla

$385.00

5.19 (1.37%)

10:58
09/19/17
09/19
10:58
09/19/17
10:58
Conference/Events
Tesla management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 02

    Oct

WK

Workiva

$19.75

-0.15 (-0.75%)

10:55
09/19/17
09/19
10:55
09/19/17
10:55
Conference/Events
Workiva to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.